Zachary Kordik
Psychiatry · Chicago, ILNPI 1578719381
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,329 of the $6,156 with a category attached, or 86.6%. 19 manufacturers reported payments, led by Johnson & Johnson at 34.1% of the total. Reporting peaked in 2024 at $2,454 and has fallen 59.5% since, to $994 in 2025. Among psychiatry clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 150 payments — averaging $41.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Takeda Pharmaceuticals U.S.A., Inc.$331
- Supernus Pharmaceuticals, Inc.$325
- Indivior Inc.$253
- Axsome Therapeutics, Inc.$252
- plus $935 from 13 others
What the payments were for
- Travel & lodging$82713%
- Food & beverage$5,32987%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 22 | $2,102 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 52 | $1,957 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $331 |
| Supernus Pharmaceuticals, Inc. | 13 | $325 |
| Indivior Inc. | 7 | $253 |
| Axsome Therapeutics, Inc. | 6 | $252 |
| Alkermes, Inc. | 10 | $218 |
| E.r. Squibb & Sons, L.L.C. | 4 | $196 |
| Otsuka America Pharmaceutical, Inc. | 6 | $140 |
| Livanova USA, Inc. | 3 | $100 |
| Lundbeck LLC | 3 | $54 |
| Bausch Health US, LLC | 2 | $47 |
| AbbVie | 2 | $35 |
| Corium, LLC | 1 | $27 |
| Braeburn Inc. | 1 | $27 |
| Currax Pharmaceuticals LLC | 2 | $26 |
| Neurocrine Biosciences, Inc. | 1 | $25 |
| USWM, LLC | 1 | $22 |
| Ironshore Pharmaceuticals Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,156 in reported general payments places this provider in the 90th percentile of 1,344 psychiatry providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylphenidate Hcl Er (Cd)Methylphenidate Hcl | 13 | $783 |
| Bupropion XlBupropion Hcl | 24 | $632 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 12 | $526 |
| Escitalopram Oxalate | 34 | $481 |
| Methylphenidate Hcl | 16 | $348 |
| Aripiprazole | 16 | $313 |
| Clonazepam | 27 | $225 |
| Trazodone Hcl | 15 | $196 |
| Duloxetine Hcl | 13 | $187 |
| Sertraline Hcl | 18 | $101 |
| Lamotrigine | 11 | $93 |
| Alprazolam | 12 | $52 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Chicago
- Mitchell GlaserChicago$752K
- Peter WeidenChicago$440K
- Michelle DeesChicago$289K
- Jeffrey RadoChicago$208K
- K Ranga KrishnanChicago$92K
- Richard BaerChicago$44K
- Adam GoldenbergChicago$23K
- Olusola AjiloreChicago$21K
- Emil CoccaroChicago$20K
- Guarava AgarwalChicago$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.